Skip to main content
Clinical Trials/NL-OMON43100
NL-OMON43100CompletedNot Applicable

Continuous glucose monitoring during diets that differ in glycemic load - GLOW<br>Glucose LOWering

nilever0 sites23 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
23

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 64 (—)

Inclusion Criteria

  • - Apparently healthy men and post-menopausal women (post-menopausal for at least one year)
  • - BMI >= 25.0 and <= 35.0 kg/m2
  • - Age: 50-70 yrs
  • - Signed informed consent

Exclusion Criteria

  • - Having a medical conditions which might affect the study measurements.
  • - Reported use of over-the-counter or prescribed medication or food supplements, which may interfere with study measurements.
  • - Use of oral antibiotics 40 days or less prior to the start of the study
  • - Reported participation in another nutritional or biomedical study 3 months before the screening or during the study
  • - Reported participation in night shift work 2 weeks prior to screening or during the study.
  • - Reported intense sporting activities > 2h/w.
  • - Reported alcohol consumption > 10 units/week (female) or > 14 units/week (male)
  • - Reported use of any nicotine containing products in the 6 months preceding the study and willing to abstain from use of nicotine containing products during the study.
  • - Reported dietary habits: medically prescribed diet, slimming diet, vegetarian.
  • - Reported weight loss/gain (> 3 kg) in the last 2 months before the study.
  • - Blood donation in the past 3 months
  • - Known allergy or intolerance to food products.

Investigators

Sponsor
nilever

Similar Trials